- Home
- SRZN vs MBOT Comparison
SRZN vs MBOT Comparison
Compare SRZN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRZN | MBOT |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 134.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SRZN | MBOT |
|---|---|---|
| Price | $19.67 | $2.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $38.50 | $8.75 |
| AVG Volume (30 Days) | 100.8K | ★ 1.6M |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,604,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $1.25 |
| 52 Week High | $24.94 | $4.67 |
Technical Indicators
Market Signals| Indicator | SRZN | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 47.61 |
| Support Level | $21.03 | $1.95 |
| Resistance Level | $23.42 | $2.14 |
| Average True Range (ATR) | 1.84 | 0.11 |
| MACD | -0.60 | -0.00 |
| Stochastic Oscillator | 28.45 | 51.39 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.